Arsenic immunotoxicity: A review

Environmental Health: A Global Access Science Source

Volumn 12, Issue 1, 2013, Pages

  Dangleben, Nygerma L ^a   Skibola, Christine F ^b   Smith, Martyn T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Arsenic; Immune system; Immunocompromised; Immunosuppression; Immunotoxicity

Indexed keywords

ARSENIC; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DRINKING WATER; F ACTIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; POLLUTANT;

ARSENIC; CANCER; IMMUNE SYSTEM; IMMUNITY; LITERATURE REVIEW; POLLUTION EFFECT; POLLUTION EXPOSURE; PUBLIC HEALTH; TOXICITY;

ACUTE TOXICITY; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIGEN BINDING; ASTHMA; BLADDER CANCER; BRONCHIECTASIS; BRONCHITIS; BRONCHUS INJURY; CANCER MORTALITY; CD4 CD8 RATIO; CELL CYCLE REGULATION; CELL FUNCTION; CERVICAL LYMPH NODE; CHRONIC DISEASE; CHRONIC INFLAMMATION; COHORT ANALYSIS; COUGHING; CROSS-SECTIONAL STUDY; DISEASE MARKER; DOWN REGULATION; ELECTRIC POWER PLANT; ENVIRONMENTAL FACTOR; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOSURVEILLANCE; IMMUNOTOXICITY; IN VITRO STUDY; INDIA; INFECTION; INNATE IMMUNITY; KIDNEY CANCER; LANGERHANS CELL; LATENT PERIOD; LONG TERM EXPOSURE; LUNG ALVEOLUS MACROPHAGE; LUNG CANCER; LUNG FUNCTION; LUNG TUBERCULOSIS; LYMPH NODE CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MATERNAL MORBIDITY; MICROARRAY ANALYSIS; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; OBSERVATIONAL STUDY; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRENATAL EXPOSURE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RESPIRATORY FAILURE; RESPIRATORY TRACT INFECTION; REVIEW; SKIN DEFECT; SKIN MANIFESTATION; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; UMBILICAL CORD BLOOD; UNITED STATES; ANIMAL; ARSENIC POISONING; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; IMMUNOLOGY; POLLUTANT; TOXICITY;

ANIMALS; ARSENIC; ARSENIC POISONING; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; HUMANS;

EID: 84884603821     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/1476-069X-12-73     Document Type: Review

References (141)

1. IARC, A Review of Human Carcinogens: Arsenic, Metals, Fibres, and Dusts vol. 100C Geneva, Switzerland: World Health Organization 2012
2. Liver is a target of arsenic carcinogenesis. Liu J, Waalkes MP, Toxicol Sci 2008 105 24 32 10.1093/toxsci/kfn120 18566022
3. Arsenic exposure and toxicology: a historical perspective. Hughes MF, Beck BD, Chen Y, Lewis AS, Thomas DJ, Toxicol Sci 2011 123 305 332 10.1093/toxsci/kfr184 21750349
4. Public health. Nordstrom DK, Worldwide occurrences of arsenic in ground water. Science 2002 296 2143 2145
5. Disruption of the arsenic (+3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate. Drobna Z, Naranmandura H, Kubachka KM, Edwards BC, Herbin-Davis K, Styblo M, Le XC, Creed JT, Maeda N, Hughes MF, Thomas DJ, Chem Res Toxicol 2009 22 1713 1720 10.1021/tx900179r 19691357
6. Methylated trivalent arsenic species are genotoxic. Mass MJ, Tennant A, Roop BC, Cullen WR, Styblo M, Thomas DJ, Kligerman AD, Chem Res Toxicol 2001 14 355 361 10.1021/tx000251l 11304123 (Pubitemid 32367468)
7. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Petrick JS, Ayala-Fierro F, Cullen WR, Carter DE, Vasken Aposhian H, Toxicol Appl Pharmacol 2000 163 203 207 10.1006/taap.1999.8872 10698679 (Pubitemid 30152096)
8. Monomethylarsonous acid (MMA(III)) and arsenite: LD(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase. Petrick JS, Jagadish B, Mash EA, Aposhian HV, Chem Res Toxicol 2001 14 651 656 10.1021/tx000264z 11409934 (Pubitemid 32565713)
9. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Styblo M, Del Razo LM, Vega L, Germolec DR, LeCluyse EL, Hamilton GA, Reed W, Wang C, Cullen WR, Thomas DJ, Arch Toxicol 2000 74 289 299 10.1007/s002040000134 11005674 (Pubitemid 30660931)
10. Arsenic methylation and skin cancer risk in southwestern Taiwan. Chen YC, Guo YL, Su HJ, Hsueh YM, Smith TJ, Ryan LM, Lee MS, Chao SC, Lee JY, Christiani DC, J Occup Environ Med 2003 45 241 248 10.1097/01.jom.0000058336.05741.e8 12661181 (Pubitemid 36347799)
11. Arsenic methylation and bladder cancer risk in case-control studies in Argentina and the United States. Steinmaus C, Bates MN, Yuan Y, Kalman D, Atallah R, Rey OA, Biggs ML, Hopenhayn C, Moore LE, Hoang BK, Smith AH, J Occup Environ Med 2006 48 478 488 10.1097/01.jom.0000200982.28276.70 16688004 (Pubitemid 43772338)
12. Arsenic-induced oxidative stress and its reversibility. Flora SJ, Free Radic Biol Med 2011 51 257 281 10.1016/j.freeradbiomed.2011.04.008 21554949
13. Some drinking-water disinfectants and contaminants, including arsenic. IARC, IARC Monogr Eval Carcinog Risks Hum, vol. 84 Geneva, Switzerland: World Health Organization 2004 1 477
14. NRC, Arsenic in Drinking Water: 2001 Update Washington, D C: National Academy Press 2001
15. Long term low-dose arsenic exposure induces loss of DNA methylation. Reichard JF, Schnekenburger M, Puga A, Biochem Biophys Res Commun 2007 352 188 192 10.1016/j.bbrc.2006.11.001 17107663 (Pubitemid 44821112)
16. Arsenic, stem cells, and the developmental basis of adult cancer. Tokar EJ, Qu W, Waalkes MP, Toxicol Sci 2011 120 Suppl 1 192 203 21071725
17. Immunotoxicity: the risk is real. Selgrade MK, Toxicol Sci 2007 100 328 332 10.1093/toxsci/kfm244 17878151 (Pubitemid 350131360)
18. Health effects of early life exposure to arsenic. Vahter M, Basic Clin Pharmacol Toxicol 2008 102 204 211 10.1111/j.1742-7843.2007.00168.x 18226075 (Pubitemid 351143425)
19. Drinking-water arsenic exposure modulates gene expression in human lymphocytes from a U.S. population. Andrew AS, Jewell DA, Mason RA, Whitfield ML, Moore JH, Karagas MR, Environ Health Perspect 2008 116 524 531 10.1289/ehp.10861 18414638 (Pubitemid 351864314)
20. Gene expression profiles in peripheral lymphocytes by arsenic exposure and skin lesion status in a Bangladeshi population. Argos M, Kibriya MG, Parvez F, Jasmine F, Rakibuz-Zaman M, Ahsan H, Cancer Epidemiol Biomarkers Prev 2006 15 1367 1375 10.1158/1055-9965.EPI-06-0106 16835338 (Pubitemid 44125296)
21. Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects. Wu MM, Chiou HY, Ho IC, Chen CJ, Lee TC, Environ Health Perspect 2003 111 1429 1438 10.1289/ehp.6396 12928151
22. Pattern of expression of apoptosis and inflammatory genes in humans exposed to arsenic and/or fluoride. Salgado-Bustamante M, Ortiz-Perez MD, Calderon-Aranda E, Estrada-Capetillo L, Nino-Moreno P, Gonzalez-Amaro R, Portales-Perez D, Sci Total Environ 2010 408 760 767 10.1016/j.scitotenv.2009. 11.016 19962721
23. Arsenic-specific stem cell selection during malignant transformation. Tokar EJ, Qu W, Liu J, Liu W, Webber MM, Phang JM, Waalkes MP, J Natl Cancer Inst 2010 102 638 649 10.1093/jnci/djq093 20339138
24. Lymphocyte proliferation kinetics and genotoxic findings in a pilot study on individuals chronically exposed to arsenic in Mexico. Ostrosky-Wegman P, Gonsebatt ME, Montero R, Vega L, Barba H, Espinosa J, Palao A, Cortinas C, Garcia-Vargas G, Del Razo LM, Cebrian M, Mutat Res 1991 250 477 482 10.1016/0027-5107(91)90204-2 1944361
25. Lymphocyte replicating ability in individuals exposed to arsenic via drinking water. Gonsebatt ME, Vega L, Montero R, Garcia-Vargas G, Del Razo LM, Albores A, Cebrian ME, Ostrosky-Wegman P, Mutat Res 1994 313 293 299 10.1016/0165-1161(94)90059-0 7523914 (Pubitemid 24302803)
26. Analysis of T-cell proliferation and cytokine secretion in the individuals exposed to arsenic. Biswas R, Ghosh P, Banerjee N, Das JK, Sau T, Banerjee A, Roy S, Ganguly S, Chatterjee M, Mukherjee A, Giri AK, Hum Exp Toxicol 2008 27 381 386 10.1177/0960327108094607 18715884
27. Oxidative damage in lymphocytes of copper smelter workers correlated to higher levels of excreted arsenic. Escobar J, Varela-Nallar L, Coddou C, Nelson P, Maisey K, Valdes D, Aspee A, Espinosa V, Rozas C, Montoya M, Mandiola C, Rodríguez FE, Acuña-Castillo C, Escobar A, Fernández R, Diaz H, Sandoval M, Imarai M, Rios M, Mediators Inflamm 2010 2010 403830 21253489
28. Antioxidant and metabolic impairment result in DNA damage in arsenic-exposed individuals with severe dermatological manifestations in Eastern India. Maiti S, Chattopadhyay S, Deb B, Samanta T, Maji G, Pan B, Ghosh A, Ghosh D, Environ Toxicol 2012 27 342 350 10.1002/tox.20647 20925122
29. Chronic arsenic exposure impairs macrophage functions in the exposed individuals. Banerjee N, Banerjee S, Sen R, Bandyopadhyay A, Sarma N, Majumder P, Das JK, Chatterjee M, Kabir SN, Giri AK, J Clin Immunol 2009 29 582 594 10.1007/s10875-009-9304-x 19513820
30. Effect of arsenic on regulatory T cells. Hernandez-Castro B, Doniz-Padilla LM, Salgado-Bustamante M, Rocha D, Ortiz-Perez MD, Jimenez-Capdeville ME, Portales-Perez DP, Quintanar-Stephano A, Gonzalez-Amaro R, J Clin Immunol 2009 29 461 469 10.1007/s10875-009-9280-1 19247822
31. Natural regulatory T cells: mechanisms of suppression. Miyara M, Sakaguchi S, Trends Mol Med 2007 13 108 116 10.1016/j.molmed.2007.01.003 17257897 (Pubitemid 46341958)
32. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, Mauri C, J Exp Med 2004 200 277 285 10.1084/jem.20040165 15280421 (Pubitemid 39031247)
33. Immunological profiles in workers of a power plant burning coal rich in arsenic content. Bencko V, Wagner V, Wagnerova M, Batora J, J Hyg Epidemiol Microbiol Immunol 1988 32 137 146 2457611
34. Association of respiratory complications and elevated serum immunoglobulins with drinking water arsenic toxicity in human. Islam LN, Nabi AH, Rahman MM, Zahid MS, J Environ Sci Health A Tox Hazard Subst Environ Eng 2007 42 1807 1814 10.1080/10934520701566777 17952781 (Pubitemid 47613766)
35. Evidence from Chile that arsenic in drinking water may increase mortality from pulmonary tuberculosis. Smith AH, Marshall G, Yuan Y, Liaw J, Ferreccio C, Steinmaus C, Am J Epidemiol 2011 173 414 420 10.1093/aje/kwq383 21190988
36. Decrements in lung function related to arsenic in drinking water in West Bengal, India. Von Ehrenstein OS, Mazumder DN, Yuan Y, Samanta S, Balmes J, Sil A, Ghosh N, Hira-Smith M, Haque R, Purushothamam R, Lahiri S, Das S, Smith AH, Am J Epidemiol 2005 162 533 541 10.1093/aje/kwi236 16093295 (Pubitemid 41253251)
37. Mortality for certain diseases in areas with high levels of arsenic in drinking water. Tsai SM, Wang TN, Ko YC, Arch Environ Health 1999 54 186 193 10.1080/00039899909602258 10444040
38. Pulmonary involvement in chronic arsenic poisoning from drinking contaminated ground-water. De BK, Majumdar D, Sen S, Guru S, Kundu S, J Assoc Physicians India 2004 52 395 400 15656029 (Pubitemid 41279751)
39. Arsenic in drinking water and the prevalence of respiratory effects in West Bengal, India. Mazumder DN, Haque R, Ghosh N, De BK, Santra A, Chakraborti D, Smith AH, Int J Epidemiol 2000 29 1047 1052 10.1093/ije/29.6.1047 11101546 (Pubitemid 32007641)
40. Respiratory effects and arsenic contaminated well water in Bangladesh. Milton AH, Rahman M, Int J Environ Health Res 2002 12 175 179 10.1080/09603120220129346 12400554
41. Non-cancer effects of chronic arsenicosis in Bangladesh: preliminary results. Milton AH, Hasan Z, Rahman A, Rahman M, J Environ Sci Health A Tox Hazard Subst Environ Eng 2003 38 301 305 10.1081/ESE-120016896 12635834 (Pubitemid 36267810)
42. Bronchiectasis in persons with skin lesions resulting from arsenic in drinking water. Mazumder DN, Steinmaus C, Bhattacharya P, Von Ehrenstein OS, Ghosh N, Gotway M, Sil A, Balmes JR, Haque R, Hira-Smith MM, Smith AH, Epidemiology 2005 16 760 765 10.1097/01.ede.0000181637.10978.e6 16222165 (Pubitemid 41681542)
43. Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Smith AH, Marshall G, Yuan Y, Ferreccio C, Liaw J, Von Ehrenstein O, Steinmaus C, Bates MN, Selvin S, Environ Health Perspect 2006 114 1293 1296 10.1289/ehp.8832 16882542 (Pubitemid 44184693)
44. Bronchiectasis: new findings in the pathogenesis and treatment of this disease. Ilowite J, Spiegler P, Chawla S, Curr Opin Infect Dis 2008 21 163 167 10.1097/QCO.0b013e3282f4f237 18317040 (Pubitemid 351641520)
45. Bronchiectasis. King P, Holdsworth S, Freezer N, Holmes P, Intern Med J 2006 36 729 737 10.1111/j.1445-5994.2006.01219.x 17040360 (Pubitemid 44563435)
46. Kidney cancer mortality: fifty-year latency patterns related to arsenic exposure. Yuan Y, Marshall G, Ferreccio C, Steinmaus C, Liaw J, Bates M, Smith AH, Epidemiology 2010 21 103 108 10.1097/EDE.0b013e3181c21e46 20010213
47. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. Marshall G, Ferreccio C, Yuan Y, Bates MN, Steinmaus C, Selvin S, Liaw J, Smith AH, J Natl Cancer Inst 2007 99 920 928 10.1093/jnci/djm004 17565158 (Pubitemid 47078729)
48. Arsenic exposure and age and sex-specific risk for skin lesions: a population-based case-referent study in Bangladesh. Rahman M, Vahter M, Sohel N, Yunus M, Wahed MA, Streatfield PK, Ekstrom EC, Persson LA, Environ Health Perspect 2006 114 1847 1852 17185274 (Pubitemid 44873684)
49. Gender and age differences in the metabolism of inorganic arsenic in a highly exposed population in Bangladesh. Lindberg AL, Ekstrom EC, Nermell B, Rahman M, Lonnerdal B, Persson LA, Vahter M, Environ Res 2008 106 110 120 10.1016/j.envres.2007.08.011 17900557 (Pubitemid 350137961)
50. Decreased urinary beta-defensin-1 expression as a biomarker of response to arsenic. Hegedus CM, Skibola CF, Warner M, Skibola DR, Alexander D, Lim S, Dangleben NL, Zhang L, Clark M, Pfeiffer RM, Steinmaus C, Smith AH, Smith MT, Moore LE, Toxicol Sci 2008 106 74 82 10.1093/toxsci/kfn104 18511430
51. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, Wilson JM, Cell 1997 88 553 560 10.1016/S0092-8674(00)81895-4 9038346 (Pubitemid 27154420)
52. Epithelial antimicrobial peptides: review and significance for oral applications. Weinberg A, Krisanaprakornkit S, Dale BA, Crit Rev Oral Biol Med 1998 9 399 414 10.1177/10454411980090040201 9825219 (Pubitemid 29402008)
53. beta-Defensin 1 contributes to pulmonary innate immunity in mice. Moser C, Weiner DJ, Lysenko E, Bals R, Weiser JN, Wilson JM, Infect Immun 2002 70 3068 3072 10.1128/IAI.70.6.3068-3072.2002 12010999 (Pubitemid 34564168)
54. Metastasis suppressor genes for prostate cancer. Ichikawa T, Nihei N, Kuramochi H, Kawana Y, Killary AM, Shimazaki J, Oshimura M, Kugoh H, Isaacs JT, Barrett JC, Rinker Schaeffer CW, Prostate Suppl 1996 6 31 35 8630227 (Pubitemid 26112286)
55. DNA copy number losses in human neoplasms. Knuutila S, Aalto Y, Autio K, Bjorkqvist AM, El-Rifai W, Hemmer S, Huhta T, Kettunen E, Kiuru-Kuhlefelt S, Larramendy ML, Lushnikova T, Monni O, Pere H, Tapper J, Tarkkanen M, Varis A, Wasenius VM, Wolf M, Zhu Y, Am J Pathol 1999 155 683 694 10.1016/S0002-9440(10) 65166-8 10487825 (Pubitemid 29426813)
56. Loss of two new loci on chromosome 8 (8p23 and 8q12-13) in human prostate cancer. Perinchery G, Bukurov N, Nakajima K, Chang J, Hooda M, Oh BR, Dahiya R, Int J Oncol 1999 14 495 500 10024682
57. Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Young AN, Amin MB, Moreno CS, Lim SD, Cohen C, Petros JA, Marshall FF, Neish AS, Am J Pathol 2001 158 1639 1651 10.1016/S0002-9440(10)64120-X 11337362 (Pubitemid 32422929)
58. Cancer-specific loss of beta-defensin 1 in renal and prostatic carcinomas. Donald CD, Sun CQ, Lim SD, Macoska J, Cohen C, Amin MB, Young AN, Ganz TA, Marshall FF, Petros JA, Lab Invest 2003 83 501 505 10.1097/01.LAB. 0000063929.61760.F6 12695553 (Pubitemid 36457704)
59. Decreased gene expression of human beta-defensin-1 in the development of squamous cell carcinoma of the oral cavity. Wenghoefer M, Pantelis A, Dommisch H, Reich R, Martini M, Allam JP, Novak N, Berge S, Jepsen S, Winter J, Int J Oral Maxillofac Surg 2008 37 660 663 10.1016/j.ijom.2008.02.003 18346877 (Pubitemid 351905974)
60. Loss of human beta-defensin 1, 2, and 3 expression in oral squamous cell carcinoma. Joly S, Compton LM, Pujol C, Kurago ZB, Guthmiller JM, Oral Microbiol Immunol 2009 24 353 360 10.1111/j.1399-302X.2009.00512.x 19702947
61. Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma. Sun CQ, Arnold R, Fernandez-Golarz C, Parrish AB, Almekinder T, He J, Ho SM, Svoboda P, Pohl J, Marshall FF, Petros JA, Cancer Res 2006 66 8542 8549 10.1158/0008-5472.CAN-06-0294 16951166 (Pubitemid 44449167)
62. Functional analysis of the host defense peptide Human Beta Defensin-1: new insight into its potential role in cancer. Bullard RS, Gibson W, Bose SK, Belgrave JK, Eaddy AC, Wright CJ, Hazen-Martin DJ, Lage JM, Keane TE, Ganz TA, Donald CD, Mol Immunol 2008 45 839 848 10.1016/j.molimm.2006.11.026 17868871 (Pubitemid 47505263)
63. Effects of arsenic on maternal and fetal health. Vahter M, Annu Rev Nutr 2009 29 381 399 10.1146/annurev-nutr-080508-141102 19575603
64. Effect of arsenic, cadmium and lead on the induction of apoptosis of normal human mononuclear cells. de la Fuente H, Portales-Perez D, Baranda L, Diaz-Barriga F, Saavedra-Alanis V, Layseca E, Gonzalez-Amaro R, Clin Exp Immunol 2002 129 69 77 10.1046/j.1365-2249.2002.01885.x 12100024
65. Apoptosis of peripheral blood mononuclear cells in children exposed to arsenic and fluoride. Rocha-Amador DO, Calderon J, Carrizales L, Costilla-Salazar R, Perez-Maldonado IN, Environ Toxicol Pharmacol 2011 32 399 405 10.1016/j.etap.2011.08.004 22004959
66. Apoptosis in the pathogenesis and treatment of disease. Thompson CB, Science 1995 267 1456 1462 10.1126/science.7878464 7878464
67. Assessment of lymphocyte subpopulations and cytokine secretion in children exposed to arsenic. Soto-Pena GA, Luna AL, Acosta-Saavedra L, Conde P, Lopez-Carrillo L, Cebrian ME, Bastida M, Calderon-Aranda ES, Vega L, Faseb J 2006 20 779 781 16461332 (Pubitemid 46671213)
68. Hautarzt. Schofer H, Roder C, Kaposi sarcoma in Caucasian women. Clinical, chemical laboratory and endocrinologic studies in 8 women with HIV-associated or classical Kaposi sarcoma 1995 46 632 637 7591768
69. Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study. Wikby A, Maxson P, Olsson J, Johansson B, Ferguson FG, Mech Ageing Dev 1998 102 187 198 10.1016/S0047-6374(97)00151-6 9720651 (Pubitemid 28353538)
70. Prognostic value of biomarkers in malignant melanoma. Hernberg M, Turunen JP, Von Boguslawsky K, Muhonen T, Pyrhonen S, Melanoma Res 1998 8 283 291 10.1097/00008390-199806000-00013 9664152 (Pubitemid 28313768)
71. The regulation of the development and function of dendritic cell subsets by GM-CSF: more than a hematopoietic growth factor. Zhan Y, Xu Y, Lew AM, Mol Immunol 2012 52 30 37 10.1016/j.molimm.2012.04.009 22580403
72. Arsenic alters monocyte superoxide anion and nitric oxide production in environmentally exposed children. Luna AL, Acosta-Saavedra LC, Lopez-Carrillo L, Conde P, Vera E, De Vizcaya-Ruiz A, Bastida M, Cebrian ME, Calderon-Aranda ES, Toxicol Appl Pharmacol 2010 245 244 251 10.1016/j.taap.2010.03.006 20226805
73. Nitric oxide and superoxide anion production in monocytes from children exposed to arsenic and lead in region Lagunera, Mexico. Pineda-Zavaleta AP, Garcia-Vargas G, Borja-Aburto VH, Acosta-Saavedra LC, Calderon-Aranda ES, Cebrian ME, Gomez-Munoz A, Vera Aguilar E, Toxicol Appl Pharmacol 2004 198 283 290 10.1016/j.taap.2003.10.034 15276407 (Pubitemid 38969957)
74. Exposure to inorganic arsenic metabolites during early human development. Concha G, Vogler G, Lezcano D, Nermell B, Vahter M, Toxicol Sci 1998 44 185 190 10.1093/toxsci/44.2.185 9742656 (Pubitemid 28415227)
75. Association of arsenic exposure during pregnancy with fetal loss and infant death: a cohort study in Bangladesh. Rahman A, Vahter M, Ekstrom EC, Rahman M, Golam Mustafa AH, Wahed MA\, Yunus M, Persson LA, Am J Epidemiol 2007 165 1389 1396 10.1093/aje/kwm025 17351293 (Pubitemid 47234306)
76. Arsenic exposure and risk of spontaneous abortion, stillbirth, and infant mortality. Rahman A, Persson LA, Nermell B, El Arifeen S, Ekstrom EC, Smith AH, Vahter M, Epidemiology 2010 21 797 804 10.1097/EDE.0b013e3181f56a0d 20864889
77. Effects of in utero arsenic exposure on child immunity and morbidity in rural Bangladesh. Raqib R, Ahmed S, Sultana R, Wagatsuma Y, Mondal D, Hoque AM, Nermell B, Yunus M, Roy S, Persson LA, Arifeen SE, Moore S, Vahter M, Toxicol Lett 2009 185 197 202 10.1016/j.toxlet.2009.01.001 19167470
78. Arsenic exposure in pregnancy increases the risk of lower respiratory tract infection and diarrhea during infancy in Bangladesh. Rahman A, Vahter M, Ekstrom EC, Persson LA, Environ Health Perspect 2011 119 719 724 21147604
79. Arsenic-associated oxidative stress, inflammation, and immune disruption in human placenta and cord blood. Ahmed S, Raqib R, Vahter M, Ekstrom EC, Moore S, Ameer SS, Gardner RM, Rekha RS, Mahabbat-e Khoda S, Environ Health Perspect 2011 119 258 264 20940111
80. In utero arsenic exposure is associated with impaired thymic function in newborns possibly via oxidative stress and apoptosis. Ahmed S, Ahsan KB, Kippler M, Mily A, Wagatsuma Y, Hoque AM, Ngom PT, El Arifeen S, Raqib R, Vahter M, Toxicol Sci 2012 129 305 314 10.1093/toxsci/kfs202 22713597
81. Exposure to arsenic at levels found inU.S. drinking water modifies expression in the mouse lung. Andrew AS, Bernardo V, Warnke LA, Davey JC, Hampton T, Mason RA, Thorpe JE, Ihnat MA, Hamilton JW, Toxicol Sci 2007 100 75 87 10.1093/toxsci/kfm200 17682005 (Pubitemid 47617805)
82. Chronic exposure to arsenic in the drinking water alters the expression of immune response genes in mouse lung. Kozul CD, Hampton TH, Davey JC, Gosse JA, Nomikos AP, Eisenhauer PL, Weiss DJ, Thorpe JE, Ihnat MA, Hamilton JW, Environ Health Perspect 2009 117 1108 1115 10.1289/ehp.0800199 19654921
83. Perturbation of defense pathways by low-dose arsenic exposure in zebrafish embryos. Mattingly CJ, Hampton TH, Brothers KM, Griffin NE, Planchart A, Environ Health Perspect 2009 117 981 987 19590694
84. Effects of arsenic on zebrafish innate immune system. Hermann AC, Kim CH, Mar Biotechnol (NY) 2005 7 494 505 10.1007/s10126-004-4109-7 (Pubitemid 41551342)
85. Effects of low concentrations of arsenic on the innate immune system of the zebrafish (Danio rerio). Nayak AS, Lage CR, Kim CH, Toxicol Sci 2007 98 118 124 10.1093/toxsci/kfm072 17400579 (Pubitemid 47073825)
86. [Study on reproductive and immune toxicity of male rats exposed to As2O3]. Xia Y, Hao G, Yang Y, Wei Sheng Yan Jiu 2009 38 720 722 20047232
87. Biochemical and immunotoxicological alterations following repeated gallium arsenide exposure and their recoveries by meso-2,3-dimercaptosuccinic acid and 2,3-dimercaptopropane 1-sulfonate administration in rats. Flora SJ, Kumar P, Environ Toxicol Pharmacol 1996 2 315 320 10.1016/S1382-6689(96)00063-4 21781736 (Pubitemid 27008061)
88. A study on behavioral, neurotoxicological, and immunotoxicological effects of subchronic arsenic treatment in rats. Schulz H, Nagymajtenyi L, Institoris L, Papp A, Siroki O, J Toxicol Environ Health A 2002 65 1181 1193 10.1080/152873902760125390 12167215 (Pubitemid 34856498)
89. Splenic cell targets in gallium arsenide-induced suppression of the primary antibody response. Sikorski EE, Burns LA, Stern ML, Luster MI, Munson AE, Toxicol Appl Pharmacol 1991 110 129 142 10.1016/0041-008X(91)90296-Q 1871769
90. Perturbations in the catfish immune responses by arsenic: organ and cell specific effects. Ghosh D, Bhattacharya S, Mazumder S, Comp Biochem Physiol C Toxicol Pharmacol 2006 143 455 463 10.1016/j.cbpc.2006.04.010 16765097 (Pubitemid 44080694)
91. Perturbations in immune responses induced by concurrent subchronic exposure to arsenic and endosulfan. Aggarwal M, Naraharisetti SB, Dandapat S, Degen GH, Malik JK, Toxicology 2008 251 51 60 10.1016/j.tox.2008.07.050 18694802
92. Arsenic interferes with the signaling transduction pathway of T cell receptor activation by increasing basal and induced phosphorylation of Lck and Fyn in spleen cells. Soto-Pena GA, Vega L, Toxicol Appl Pharmacol 2008 230 216 226 10.1016/j.taap.2008.02.029 18407307
93. Long-term exposure to arsenic affects head kidney and impairs humoral immune responses of Clarias batrachus. Ghosh D, Datta S, Bhattacharya S, Mazumder S, Aquat Toxicol 2007 81 79 89 10.1016/j.aquatox.2006.11.004 17182119 (Pubitemid 46080490)
94. Immunotoxicity of the semiconductor gallium arsenide in female B6C3F1 mice. Sikorski EE, McCay JA, White KL Jr, Bradley SG, Munson AE, Fundam Appl Toxicol 1989 13 843 858 10.1016/0272-0590(89)90338-2 2695379 (Pubitemid 20061139)
95. Immunotoxicity and biodistribution analysis of arsenic trioxide in C57Bl/6 mice following a 2-week inhalation exposure. Burchiel SW, Mitchell LA, Lauer FT, Sun X, McDonald JD, Hudson LG, Liu KJ, Toxicol Appl Pharmacol 2009 241 253 259 10.1016/j.taap.2009.09.019 19800901
96. The effect of methylmercury, tetraethyl lead, and sodium arsenite on the humoral immune response in mice. Blakley BR, Sisodia CS, Mukkur TK, Toxicol Appl Pharmacol 1980 52 245 254 10.1016/0041-008X(80)90111-8 6892663 (Pubitemid 10166792)
97. Pathological, immunological and biochemical markers of subchronic arsenic toxicity in rats. Nain S, Smits JE, Environ Toxicol 2010 4 244 254
98. Reversal of gallium arsenide-induced suppression of the antibody-forming cell response by vehicle supernatants. II. Nature and identification of reversing factors. Burns LA, Munson AE, J Pharmacol Exp Ther 1993 265 150 158 8474002 (Pubitemid 23320955)
99. Arsenic-induced alterations in the contact hypersensitivity response in Balb/c mice. Patterson R, Vega L, Trouba K, Bortner C, Germolec D, Toxicol Appl Pharmacol 2004 198 434 443 10.1016/j.taap.2003.10.012 15276424 (Pubitemid 38969973)
100. Sensitivity of wild cotton rats (Sigmodon hispidus) to the immunotoxic effects of low-level arsenic exposure. Savabieasfahani M, Lochmiller RL, Rafferty DP, Sinclair JA, Arch Environ Contam Toxicol 1998 34 289 296 10.1007/s002449900320 9504978 (Pubitemid 28134384)
101. Modulation of murine peritoneal macrophage function by chronic exposure to arsenate in drinking water. Arkusz J, Stanczyk M, Lewiniska D, Stepnik M, Immunopharmacol Immunotoxicol 2005 27 315 330 10.1081/IPH-200067947 16114513 (Pubitemid 41098460)
102. Evaluation of phagocytic activity and nitric oxide generation by molluscan haemocytes as biomarkers of inorganic arsenic exposure. Chakraborty S, Ray M, Ray S, Biomarkers 2009 14 539 546 10.3109/13547500903240473 19747087
103. Effect of lead and arsenic on murine macrophage response. Sengupta M, Bishayi B, Drug Chem Toxicol 2002 25 459 472 10.1081/DCT-120014796 12378952
104. Effect of arsenic exposure on alveolar macrophage function. I. Effect of soluble as(III) and as(V). Lantz RC, Parliman G, Chen GJ, Carter DE, Environ Res 1994 67 183 195 10.1006/enrs.1994.1073 7982393
105. Intracellular survival of Staphylococcus aureus due to alteration of cellular activity in arsenic and lead intoxicated mature Swiss albino mice. Bishayi B, Sengupta M, Toxicology 2003 184 31 39 10.1016/S0300-483X(02)00549-8 12505374 (Pubitemid 36013451)
106. Suppression of splenic accessory cell function in mice exposed to gallium arsenide. Sikorski EE, Burns LA, McCoy KL, Stern M, Munson AE, Toxicol Appl Pharmacol 1991 110 143 156 10.1016/0041-008X(91)90297-R 1714636
107. Arsenic trioxide attenuated the rejection of major histocompatibility complex fully-mismatched cardiac allografts in mice. Yan S, Zhang QY, Zhou B, Xue L, Chen H, Wang Y, Zheng SS, Transplant Proc 2009 41 1855 1858 10.1016/j.transproceed.2009.02.073 19545743
108. Arsenic trioxide prevents murine sclerodermatous graft-versus-host disease. Kavian N, Marut W, Servettaz A, Laude H, Nicco C, Chereau C, Weill B, Batteux F, J Immunol 2012 188 5142 5149 10.4049/jimmunol.1103538 22491256
109. Effect of oral chronic intoxication with sodium arsenite on murine giardiasis. Escudero-Lourdes C, Martinez FD, Calvillo RQ, Medina de la Garza CE, Proc West Pharmacol Soc 2005 48 92 99 16416670 (Pubitemid 43053810)
110. Low-dose arsenic compromises the immune response to influenza A infection in vivo. Kozul CD, Ely KH, Enelow RI, Hamilton JW, Environ Health Perspect 2009 117 1441 1447 19750111
111. Role of low dosage arsenic trioxide on pulmonary dendritic cells in asthmatic mice. Lin-fu Z, Kai-sheng Y, Zhi-min Z, Chin J Integr Med 2003 9 281 284 10.1007/BF02838615
112. Effects and mechanism of arsenic trioxide on reversing the asthma pathologies including Th17-IL-17 axis in a mouse model. Zhang L, Li K, Bing Ma L, Gong SB, Wang GY, Liu Y, Ji XY, Xu L, Liu SK, Chen P, Ouyang RY, Xiang XD, Iran J Allergy Asthma Immunol 2012 11 133 145 22761187
113. Inorganic arsenic alters expression of immune and stress response genes in activated primary human T lymphocytes. Martin-Chouly C, Morzadec C, Bonvalet M, Galibert MD, Fardel O, Vernhet L, Mol Immunol 2011 48 956 965 10.1016/j.molimm.2011.01.005 21281968
114. Inorganic arsenic impairs proliferation and cytokine expression in human primary T lymphocytes. Morzadec C, Bouezzedine F, Macoch M, Fardel O, Vernhet L, Toxicology 2012 300 46 56 10.1016/j.tox.2012.05.025 22683347
115. Sodium arsenite-induced inhibition of cell proliferation is related to inhibition of IL-2 mRNA expression in mouse activated T cells. Conde P, Acosta-Saavedra LC, Goytia-Acevedo RC, Calderon-Aranda ES, Arch Toxicol 2007 81 251 259 10.1007/s00204-006-0152-7 17009048 (Pubitemid 46434777)
116. Age-related effects of sodium arsenite on splenocyte proliferation and Th1/Th2 cytokine production. Cho Y, Ahn KH, Back MJ, Choi JM, Ji JE, Won JH, Fu Z, Jang JM, Kim DK, Arch Pharm Res 2012 35 375 382 10.1007/s12272-012-0219-3 22370793
117. Sodium arsenite mediated immuno-disruption through alteration of transcription profile of cytokines in chicken splenocytes under in vitro system. Das S, Pan D, Bera AK, Rana T, Bhattacharya D, Bandyapadyay S, De S, Sreevatsava V, Bhattacharya S, Das SK, Bandyopadhayay S, Mol Biol Rep 2011 38 171 176 10.1007/s11033-010-0091-5 20339924
118. Toxic effects of various pollutants in 11B7501 lymphoma B cell line from harbour seal (Phoca vitulina). Frouin H, Fortier M, Fournier M, Toxicology 2010 270 66 76 10.1016/j.tox.2010.01.014 20116412
119. The effects of arsenic compounds on human and bovine lymphocyte mitogenesis in vitro. McCabe M, Maguire D, Nowak M, Environ Res 1983 31 323 331 10.1016/0013-9351(83)90010-5 6884293 (Pubitemid 13024065)
120. Inorganic arsenic represses interleukin-17A expression in human activated Th17 lymphocytes. Morzadec C, Macoch M, Robineau M, Sparfel L, Fardel O, Vernhet L, Toxicol Appl Pharmacol 2012 262 217 222 10.1016/j.taap.2012.05.004 22617429
121. Inorganic arsenic impairs differentiation and functions of human dendritic cells. Macoch M, Morzadec C, Fardel O, Vernhet L, Toxicol Appl Pharmacol 2013 266 204 213 10.1016/j.taap.2012.11.008 23164666
122. Differential effect of sodium arsenite during the activation of human CD4+ and CD8+ T lymphocytes. Tenorio EP, Saavedra R, Int Immunopharmacol 2005 5 1853 1869 10.1016/j.intimp.2005.06.006 16275621 (Pubitemid 41586225)
123. Interaction between arsenic trioxide and human primary cells: emphasis on human cells of myeloid origin. Binet F, Antoine F, Girard D, Inflamm Allergy Drug Targets 2009 8 21 27 10.2174/187152809787582516 19275690
124. The semiconductor elements arsenic and indium induce apoptosis in rat thymocytes. Bustamante J, Dock L, Vahter M, Fowler B, Orrenius S, Toxicology 1997 118 129 136 10.1016/S0300-483X(96)03607-4 9129167 (Pubitemid 27140456)
125. Immunosuppression by arsenic: a comparison of cathepsin L inhibition and apoptosis. Harrison MT, McCoy KL, Int Immunopharmacol 2001 1 647 656 10.1016/S1567-5769(00)00048-5 11357877 (Pubitemid 32206526)
126. Arsenic trioxide induces apoptosis of human monocytes during macrophagic differentiation through nuclear factor-kappaB-related survival pathway down-regulation. Lemarie A, Morzadec C, Merino D, Micheau O, Fardel O, Vernhet L, J Pharmacol Exp Ther 2006 316 304 314 16174796 (Pubitemid 41832610)
127. Chronic exposure to arsenic sensitizes CD3+ and CD56+ human cells to sodium arsenite-mediated apoptosis. Gonzalez-Rangel Y, Portales-Perez DP, Galicia-Cruz O, Escudero-Lourdes C, Proc West Pharmacol Soc 2005 48 89 91 16416669 (Pubitemid 43053809)
128. Enhancement of the immune response in vitro by arsenic. Yoshida T, Shimamura T, Shigeta S, Int J Immunopharmacol 1987 9 411 415 10.1016/0192-0561(87)90068-3 2956202 (Pubitemid 17080255)
129. Low-dose synergistic immunosuppression of T-dependent antibody responses by polycyclic aromatic hydrocarbons and arsenic in C57BL/6J murine spleen cells. Li Q, Lauer FT, Liu KJ, Hudson LG, Burchiel SW, Toxicol Appl Pharmacol 2010 245 344 351 10.1016/j.taap.2010.03.020 20353797
130. Human macrophages constitute targets for immunotoxic inorganic arsenic. Lemarie A, Morzadec C, Bourdonnay E, Fardel O, Vernhet L, J Immunol 2006 177 3019 3027 16920938 (Pubitemid 44277818)
131. Evaluation of immunotoxic and immunodisruptive effects of inorganic arsenite on human monocytes/macrophages. Sakurai T, Ohta T, Tomita N, Kojima C, Hariya Y, Mizukami A, Fujiwara K, Int Immunopharmacol 2006 6 304 315 10.1016/j.intimp.2005.06.012 16459422 (Pubitemid 43052829)
132. Lipoic acid ameliorates arsenic trioxide-induced HO-1 expression and oxidative stress in THP-1 monocytes and macrophages. Wang L, Weng CY, Wang YJ, Wu MJ, Chem Biol Interact 2011 190 129 138 10.1016/j.cbi.2011.02.001 21315065
133. Redox-sensitive regulation of gene expression in human primary macrophages exposed to inorganic arsenic. Bourdonnay E, Morzadec C, Fardel O, Vernhet L, J Cell Biochem 2009 107 537 547 10.1002/jcb.22155 19350554
134. Global effects of inorganic arsenic on gene expression profile in human macrophages. Bourdonnay E, Morzadec C, Sparfel L, Galibert MD, Jouneau S, Martin-Chouly C, Fardel O, Vernhet L, Mol Immunol 2009 46 649 656 10.1016/j.molimm.2008.08.268 19128835
135. Arsenic promotes ubiquitinylation and lysosomal degradation of cystic fibrosis transmembrane conductance regulator (CFTR) chloride channels in human airway epithelial cells. Bomberger JM, Coutermarsh BA, Barnaby RL, Stanton BA, J Biol Chem 2012 287 17130 17139 10.1074/jbc.M111.338855 22467879
136. Arsenic inhibits SGK1 activation of CFTR Cl- channels in the gill of killifish, Fundulus heteroclitus. Shaw JR, Bomberger JM, VanderHeide J, LaCasse T, Stanton S, Coutermarsh B, Barnaby R, Stanton BA, Aquat Toxicol 2010 98 157 164 10.1016/j.aquatox.2010.02.001 20207026
137. Arsenic upregulates MMP-9 and inhibits wound repair in human airway epithelial cells. Olsen CE, Liguori AE, Zong Y, Lantz RC, Burgess JL, Boitano S, Am J Physiol Lung Cell Mol Physiol 2008 295 293 302 10.1152/ajplung.00134.2007 18539681
138. Arsenic Alters ATP-Dependent Ca2+ Signaling in Human Airway Epithelial Cell Wound Response. Sherwood CL, Lantz RC, Burgess JL, Boitano S, Toxicol Sci 2011 121 191 206 10.1093/toxsci/kfr044 21357385
139. Environmental arsenic exposure and sputum metalloproteinase concentrations. Josyula AB, Poplin GS, Kurzius-Spencer M, McClellen HE, Kopplin MJ, Sturup S, Clark Lantz R, Burgess JL, Environ Res 2006 102 283 290 10.1016/j.envres.2006.01.003 16487958 (Pubitemid 44559781)
140. Role of oxidative stress in arsenic-induced toxicity. Lantz RC, Hays AM, Drug Metab Rev 2006 38 791 804 10.1080/03602530600980108 17145702 (Pubitemid 44903269)
141. Pulmonary biomarkers based on alterations in protein expression after exposure to arsenic. Lantz RC, Lynch BJ, Boitano S, Poplin GS, Littau S, Tsaprailis G, Burgess JL, Environ Health Perspect 2007 115 586 591 10.1289/ehp.9611 17450228 (Pubitemid 46585531)